<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1448" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1448/" /><meta name="ncbi_pagename" content="Zellweger Spectrum Disorder - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Zellweger Spectrum Disorder - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Zellweger Spectrum Disorder" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/12/21" /><meta name="citation_author" content="Steven J Steinberg" /><meta name="citation_author" content="Gerald V Raymond" /><meta name="citation_author" content="Nancy E Braverman" /><meta name="citation_author" content="Ann B Moser" /><meta name="citation_pmid" content="20301621" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1448/" /><meta name="citation_keywords" content="ZSD" /><meta name="citation_keywords" content="ZSD" /><meta name="citation_keywords" content="Zellweger Syndrome" /><meta name="citation_keywords" content="Neonatal Adrenoleukodystrophy" /><meta name="citation_keywords" content="Infantile Refsum Disease" /><meta name="citation_keywords" content="Peroxisomal biogenesis factor 19" /><meta name="citation_keywords" content="Peroxisomal biogenesis factor 3" /><meta name="citation_keywords" content="Peroxisomal membrane protein 11B" /><meta name="citation_keywords" content="Peroxisomal membrane protein PEX13" /><meta name="citation_keywords" content="Peroxisomal membrane protein PEX14" /><meta name="citation_keywords" content="Peroxisomal membrane protein PEX16" /><meta name="citation_keywords" content="Peroxisomal targeting signal 1 receptor" /><meta name="citation_keywords" content="Peroxisome assembly factor 2" /><meta name="citation_keywords" content="Peroxisome assembly protein 12" /><meta name="citation_keywords" content="Peroxisome assembly protein 26" /><meta name="citation_keywords" content="Peroxisome biogenesis factor 1" /><meta name="citation_keywords" content="Peroxisome biogenesis factor 10" /><meta name="citation_keywords" content="Peroxisome biogenesis factor 2" /><meta name="citation_keywords" content="PEX1" /><meta name="citation_keywords" content="PEX10" /><meta name="citation_keywords" content="PEX11B" /><meta name="citation_keywords" content="PEX12" /><meta name="citation_keywords" content="PEX13" /><meta name="citation_keywords" content="PEX14" /><meta name="citation_keywords" content="PEX16" /><meta name="citation_keywords" content="PEX19" /><meta name="citation_keywords" content="PEX2" /><meta name="citation_keywords" content="PEX26" /><meta name="citation_keywords" content="PEX3" /><meta name="citation_keywords" content="PEX5" /><meta name="citation_keywords" content="PEX6" /><meta name="citation_keywords" content="Zellweger Spectrum Disorder" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Zellweger Spectrum Disorder" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Steven J Steinberg" /><meta name="DC.Contributor" content="Gerald V Raymond" /><meta name="DC.Contributor" content="Nancy E Braverman" /><meta name="DC.Contributor" content="Ann B Moser" /><meta name="DC.Date" content="2017/12/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1448/" /><meta name="description" content="Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term &quot;ZSD&quot; is now used to refer to all individuals with a PEX gene defect regardless of phenotype." /><meta name="og:title" content="Zellweger Spectrum Disorder" /><meta name="og:type" content="book" /><meta name="og:description" content="Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term &quot;ZSD&quot; is now used to refer to all individuals with a PEX gene defect regardless of phenotype." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1448/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/pbd/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1448/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CE65EE042A49100000000004E001D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1448_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1448_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/zap70-scid/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/archived_chapters/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1448_"><span class="title" itemprop="name">Zellweger Spectrum Disorder</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: ZSD</div><p class="contrib-group"><span itemprop="author">Steven J Steinberg</span>, PhD, <span itemprop="author">Gerald V Raymond</span>, MD, <span itemprop="author">Nancy E Braverman</span>, MS, MD, and <span itemprop="author">Ann B Moser</span>, BA.</p><a data-jig="ncbitoggler" href="#__NBK1448_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1448_ai__"><div class="contrib half_rhythm"><span itemprop="author">Steven J Steinberg</span>, PhD<div class="affiliation small">ARUP Laboratories<br />Salt Lake City, Utah<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.balpura@grebniets.nevets" class="oemail">moc.balpura@grebniets.nevets</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Gerald V Raymond</span>, MD<div class="affiliation small">Departments of Pediatric and Neurology<br />Penn State Children's Hospital<br />Hershey, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usp.htlaehetatsnnep@dnomyarg" class="oemail">ude.usp.htlaehetatsnnep@dnomyarg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nancy E Braverman</span>, MS, MD<div class="affiliation small">Departments of Human Genetics McGill University - Montreal Children's Hospital Research Institute<br />Montreal, Quebec, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.lligcm@namrevarb.ycnan" class="oemail">ac.lligcm@namrevarb.ycnan</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ann B Moser</span>, BA<div class="affiliation small">The Peroxisomal Diseases Laboratory<br />Kennedy Krieger Institute<br />Department of Neurology<br />Johns Hopkins University School of Medicine<br />Baltimore, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.regeirkydennek@aresom" class="oemail">gro.regeirkydennek@aresom</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 12, 2003</span>; Last Revision: <span itemprop="dateModified">December 21, 2017</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="pbd.Summary" itemprop="description"><h2 id="_pbd_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defect regardless of <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and other long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress.</p><p>Individuals with intermediate/milder ZSD do not have <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss); neurologic involvement (ataxia, polyneuropathy, and leukodystrophy); liver dysfunction; adrenal insufficiency; and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of ZSD is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the suggestive clinical and biochemical findings above and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the 13 known ZSD-PEX genes.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> The focus is on symptomatic therapy and may include gastrostomy to provide adequate calories, hearing aids, cataract removal in infancy, glasses, vitamin supplementation, primary bile acid therapy, adrenal replacement, antiepileptic drugs, and possibly monitoring for hyperoxaluria.</p><p><i>Surveillance</i>: Annual hearing and ophthalmologic evaluations, monitoring of liver function and coagulation factors, ACTH/cortisol. A baseline brain MRI is recommended; a loss of motor and cognitive milestones could indicate a leukodystrophy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ZSD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if both ZSD-related pathogenic variants have been identified in an affected family member. Prenatal diagnosis by biochemical testing is also possible; however, the biochemical defects in cultured fibroblasts from an affected family member must be confirmed first, since the biochemical defects present in body fluids or liver may not be detectable in cultured cells (a phenomenon called "peroxisomal <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a>").</p></div></div><div id="pbd.GeneReview_Scope"><h2 id="_pbd_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="pbd.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1448/table/pbd.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pbd.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pbd.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Zellweger Spectrum Disorder: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_pbd.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Zellweger syndrome</div></li><li class="half_rhythm"><div>Neonatal adrenoleukodystrophy</div></li><li class="half_rhythm"><div>Infantile Refsum disease</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#pbd.Nomenclature"><u>Nomenclature</u></a>.</p></div></dd></dl></div></div></div></div><div id="pbd.Diagnosis"><h2 id="_pbd_Diagnosis_">Diagnosis</h2><div id="pbd.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Zellweger spectrum disorder (ZSD) <b>should be suspected</b> in children with the following clinical and laboratory findings.</p><p><b>Clinical findings.</b> Newborns with:</p><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Poor feeding</div></li><li class="half_rhythm"><div>Distinctive facies</div></li><li class="half_rhythm"><div>Brain malformations</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Renal cysts</div></li><li class="half_rhythm"><div>Hepatomegaly, cholestasis, and hepatic dysfunction</div></li><li class="half_rhythm"><div>Bony stippling (chondrodysplasia punctata) of the patella(e) and other long bones</div></li></ul><p>Older infants and children with:</p><ul><li class="half_rhythm"><div>Developmental delays with or without hypotonia (Note: Intellect can be normal.)</div></li><li class="half_rhythm"><div>Failure to thrive</div></li><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Vision impairment</div></li><li class="half_rhythm"><div>Liver dysfunction</div></li><li class="half_rhythm"><div>Adrenal dysfunction</div></li><li class="half_rhythm"><div>Leukodystrophy</div></li><li class="half_rhythm"><div>Peripheral neuropathy and ataxia</div></li></ul><p><b>Laboratory findings.</b> The screening assays for ZSD are summarized in <a class="figpopup" href="/books/NBK1448/table/pbd.T.screening_assays_for_zsd/?report=objectonly" target="object" rid-figpopup="figpbdTscreeningassaysforzsd" rid-ob="figobpbdTscreeningassaysforzsd">Table 1</a>. Note that because some individuals with ZSD do not have abnormalities of these screening assays in body fluids or cultured cells, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is necessary to establish the diagnosis (see <a href="#pbd.Establishing_the_Diagnosis">Establishing the Diagnosis</a>). Functional testing in fibroblasts remains an ancillary tool to confirm equivocal molecular and/or biochemical results.</p><div id="pbd.T.screening_assays_for_zsd" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Screening Assays for ZSD</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1448/table/pbd.T.screening_assays_for_zsd/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pbd.T.screening_assays_for_zsd_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Compound</th><th id="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test</th><th id="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Expected Findings</th><th id="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Limitations of Test</th></tr></thead><tbody><tr><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very-long-chain fatty acids (VLCFA)</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma concentration</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Elevated plasma concentrations of C26:0 &#x00026; C26:1; elevated ratios of C24/C22 &#x00026; C26/C22&#x000a0;<sup>1</sup></td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Non-fasting samples, hemolyzed samples, or an individual on a ketogenic diet can cause false positive results. Normal in RCDP.</td></tr><tr><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phytanic acid &#x00026; pristanic acid&#x000a0;<sup>2</sup></td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma concentration</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased concentrations of phytanic acid &#x00026;/or pristanic acid</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Branched-chain fatty acid accumulation depends on dietary intake of phytanic acid, which is minimal in formula- &#x00026; breast-fed infants. Thus, phytanic &#x00026; pristanic acid levels are normal in a neonate w/ZSD.</td></tr><tr><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasmalogens</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Erythrocyte membrane concentrations</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduced amounts of C16 &#x00026; C18 plasmalogens</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Individuals w/mild ZSD may have marginally reduced to normal plasmalogen levels.</td></tr><tr><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pipecolic acid</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma/urine concentration</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased concentration of pipecolic acid in both plasma &#x00026; urine</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Urinary excretion of pipecolic acid is high in neonatal period, but diminishes w/age.&#x000a0;<sup>3</sup> Thus, urine should be tested in a neonate &#x00026; plasma in an older child.</td></tr><tr><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bile acids</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma/urine concentration</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased concentrations of C27 bile acid intermediates THCA &#x00026; DHCA</td><td headers="hd_h_pbd.T.screening_assays_for_zsd_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In most cases plasma testing is more sensitive than urine analysis.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">DHCA = dihydroxycholestanoic acid; RCDP = <a href="/books/n/gene/rcdp/">rhizomelic chondrodysplasia punctata</a>; THCA = trihydroxycholestanoic acid</p></div></dd><dt>1. </dt><dd><div id="pbd.TF.1.1"><p class="no_margin">Low plasma concentration of LDL and HDL can cause false negative results. In a person with low plasma concentrations of LDL and HDL without a defect in peroxisomal fatty acid metabolism, the plasma concentration of specific fatty acids (e.g., C22:0, C24:0, C26:0) are significantly lower than normal control levels. Individuals with defects in peroxisomal fatty acid metabolism and very low LDL and HDL concentrations do not have significant elevations in C26:0 and C26:1, but do have modest elevations in the ratios of C24/C22 and C26/C22.</p></div></dd><dt>2. </dt><dd><div id="pbd.TF.1.2"><p class="no_margin">This analysis is usually included in VLCFA measurement.</p></div></dd><dt>3. </dt><dd><div id="pbd.TF.1.3"><p class="no_margin">Pipecolic acid measurement is an adjunct to more definitive biomarkers such as plasma VLCFA and erythrocyte plasmalogen levels. Elevations in pipecolic acid can also occur in <a href="/books/n/gene/pds/">pyridoxine-dependent seizures</a> [<a class="bk_pop" href="#pbd.REF.plecko.2000.121">Plecko et al 2000</a>].</p></div></dd></dl></div></div></div></div><div id="pbd.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of ZSD <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the suggestive clinical and biochemical findings above and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the 13 PEX genes listed in <a class="figpopup" href="/books/NBK1448/table/pbd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figpbdTmoleculargenetictestingusedin" rid-ob="figobpbdTmoleculargenetictestingusedin">Table 2</a>.</p><p>Molecular genetic testing approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) or more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> or <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>).</b> Gene-targeted testing requires that the clinician determine which gene(s) are likely involved, whereas genomic testing does not. Individuals with the suggestive clinical and biochemical findings of ZSD described in <a href="#pbd.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#pbd.Option_1">Option 1</a>), whereas those with a nondistinct <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that does not suggest a specific diagnosis are more likely to be diagnosed using genomic testing (see <a href="#pbd.Option_2">Option 2</a>). Note: Single-gene testing (i.e., <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of one of the PEX genes, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended. A multigene panel and/or exome sequencing are typically used in lieu of single-gene testing.</p><div id="pbd.Option_1"><h4>Option 1</h4><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> for peroxisome biogenesis disorders should include the 13 genes listed in <a class="figpopup" href="/books/NBK1448/table/pbd.T.screening_assays_for_zsd/?report=objectonly" target="object" rid-figpopup="figpbdTscreeningassaysforzsd" rid-ob="figobpbdTscreeningassaysforzsd">Table 1</a> as well as some of the disorders with similar clinical or laboratory findings that are the <a href="#pbd.Differential_Diagnosis">differential diagnosis of ZSD</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="pbd.Option_2"><h4>Option 2</h4><p>When the patient's findings do not lead to consideration of ZSD, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when clinically available) is likely to be the diagnostic modality selected. Comprehensive genomic testing includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="pbd.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Zellweger Spectrum Disorder (ZSD)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1448/table/pbd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pbd.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><td rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></td><td rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">% of ZSD Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>3</sup></td><td colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>4</sup> Detectable by Method</td></tr><tr><td colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5,&#x000a0;6</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX1</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60.5%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~98%&#x000a0;<sup>8</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~2%&#x000a0;<sup>8</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX6</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14.5%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">77/77&#x000a0;<sup>9,&#x000a0;10</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX12</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7.6%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">43/43&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX26</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.2%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/17&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX10</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.4%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/18&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX2</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.1%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19/22&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX5</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2.0%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13/13&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX13</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.5%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/7&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX16</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.1%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8/8&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX3</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.7%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/3&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX19</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.6%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/3&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX14</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.5%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/2&#x000a0;<sup>9</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX11&#x003b2;</i></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.1%</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/1&#x000a0;<sup>12</sup></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="pbd.TF.2.1"><p class="no_margin">Genes are listed from most frequent to least frequent genetic cause of ZSD.</p></div></dd><dt>2. </dt><dd><div id="pbd.TF.2.2"><p class="no_margin">See <a href="/books/NBK1448/#pbd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="pbd.TF.2.3"><p class="no_margin">Based on complementation studies using somatic cell hybridization and/or <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> complementation analysis in 810 patients with biochemical confirmation of ZSD (197 at Kennedy Krieger Institute [unpublished] and 613 reported by <a class="bk_pop" href="#pbd.REF.ebberink.2011.59">Ebberink et al [2011]</a>).</p></div></dd><dt>4. </dt><dd><div id="pbd.TF.2.4"><p class="no_margin">See <a href="#pbd.Molecular_Genetics">Molecular Genetics</a> for information on pathogenic allelic variants detected.</p></div></dd><dt>5. </dt><dd><div id="pbd.TF.2.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="pbd.TF.2.6"><p class="no_margin">An estimate, based on the assumption that large deletions or promoter and deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> pathogenic variants would be missed; however, these types of variants do not appear to be common in ZSD.</p></div></dd><dt>7. </dt><dd><div id="pbd.TF.2.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>8. </dt><dd><div id="pbd.TF.2.8"><p class="no_margin">This estimate is based on the number of individuals identified with a <i>PEX1</i> defect, defined by having two pathogenic <i>PEX1</i> variants, one of which was a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> detected by MLPA [Molly Sheridan, PhD; Johns Hopkins DNA Diagnostic Laboratory].</p></div></dd><dt>9. </dt><dd><div id="pbd.TF.2.9"><p class="no_margin">Based on <a class="bk_pop" href="#pbd.REF.ebberink.2011.59">Ebberink et al [2011]</a>, Table 1. The numerator is the number of individuals belonging to this complementation group who had two pathogenic variants identified and the denominator is the total number of individuals belonging to this complementation group who underwent sequencing of that <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>10. </dt><dd><div id="pbd.TF.2.10"><p class="no_margin">One <i>PEX6</i> variant, c.2578C&#x0003e;T (p.Arg860Trp), has been associated with ZSD in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state due to allelic expression imbalance dependent on allelic background [<a class="bk_pop" href="#pbd.REF.falkenberg.2017.965">Falkenberg et al [2017]</a>; see <a href="#pbd.Molecular_Genetics">Molecular Genetics</a>.</p></div></dd><dt>11. </dt><dd><div id="pbd.TF.2.11"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>12. </dt><dd><div id="pbd.TF.2.12"><p class="no_margin"><i>PEX11&#x003b2;</i>: <a class="bk_pop" href="#pbd.REF.ebberink.2012.307">Ebberink et al [2012]</a>, single case report</p></div></dd></dl></div></div></div></div></div></div><div id="pbd.Clinical_Characteristics"><h2 id="_pbd_Clinical_Characteristics_">Clinical Characteristics</h2><div id="pbd.Clinical_Description"><h3>Clinical Description</h3><p>Zellweger spectrum disorder (ZSD) is defined by a continuum of three phenotypes described before the biochemical and molecular bases of these disorders had been fully determined: Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), and infantile <a href="/books/n/gene/refsum/">Refsum disease</a> (IRD) [<a class="bk_pop" href="#pbd.REF.braverman.2016">Braverman et al 2016</a>].</p><p>The ZSD phenotypic spectrum is broad; some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have mild manifestations, mainly sensory deficits and/or mild developmental delay. Recently, individuals with normal intellect have been identified [<a class="bk_pop" href="#pbd.REF.ratbi.2015.535">Ratbi et al 2015</a>, <a class="bk_pop" href="#pbd.REF.ratbi.2016.507">Ratbi et al 2016</a>, <a class="bk_pop" href="#pbd.REF.smith.2016.1565">Smith et al 2016</a>] by <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing methods. Nonetheless, all of the peroxisome assembly disorders cause significant morbidity, frequently resulting in death in childhood.</p><p>Although the phenotypic designations listed above may be useful when evaluating undiagnosed individuals and counseling their families, one should not place too much emphasis on assigning a phenotypic label to an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual given that these phenotypes lie on a continuum. Thus, the terms "severe," "intermediate," and "milder" ZSD are now preferred. Because of the breadth of the phenotypic spectrum, individuals with ZSD mainly come to clinical attention in the newborn period or later in childhood. Occasionally, the subtlety of symptoms delays diagnosis until adulthood.</p><p><b>Newborns</b> are hypotonic with resultant poor feeding. Neonatal seizures are frequent and caused by underlying neuronal migration defects. Liver dysfunction may be evident as neonatal jaundice and elevation in liver function tests. Distinctive craniofacial features include flat face, broad nasal bridge, large anterior fontanelle, and widely split sutures. In severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children, bony stippling (chondrodysplasia punctata) at the patella(e) and other long bones may be noted, as well as renal cysts.</p><p><b>Older children</b> manifest retinal dystrophy, sensorineural hearing loss, developmental delay with hypotonia, and liver dysfunction. Children may first come to attention because of a failed hearing screen. Onset and severity of the hearing and visual problems vary. A few children with a clinical diagnosis of neonatal adrenoleukodystrophy had transient leopard spot pigmentary retinopathy [<a class="bk_pop" href="#pbd.REF.lyons.2004.191">Lyons et al 2004</a>]. Liver dysfunction may be first identified in children with severe bleeding episodes caused by a vitamin K-responsive coagulopathy. Older children may develop adrenal insufficiency [<a class="bk_pop" href="#pbd.REF.berendse.2014.133">Berendse et al 2014</a>] and osteopenia [<a class="bk_pop" href="#pbd.REF.rush.2016.33">Rush et al 2016</a>].</p><p><b>Adults</b> rarely are diagnosed with ZSD, but exceptions have been reported. Usually these are individuals with predominantly sensory deficits but normal neurologic development [<a class="bk_pop" href="#pbd.REF.moser.1995.13">Moser et al 1995</a>, <a class="bk_pop" href="#pbd.REF.raasrothschild.2002.1062">Raas-Rothschild et al 2002</a>, <a class="bk_pop" href="#pbd.REF.majewski.2011.593">Majewski et al 2011</a>, <a class="bk_pop" href="#pbd.REF.ratbi.2015.535">Ratbi et al 2015</a>, <a class="bk_pop" href="#pbd.REF.ratbi.2016.507">Ratbi et al 2016</a>, <a class="bk_pop" href="#pbd.REF.smith.2016.1565">Smith et al 2016</a>].</p><p><b>Severe ZSD</b> (previously called Zellweger syndrome [ZS]) typically presents in the neonatal period with profound hypotonia, characteristic facies, gyral malformations, seizures, inability to feed, renal cysts, hepatic dysfunction, and chondrodysplasia punctata. Infants with severe ZSD are significantly impaired and usually die during the first year of life, usually having made no developmental progress. Death is usually secondary to progressive apnea or respiratory compromise from infection.</p><p><b>Intermediate/milder ZSD</b> (previously called neonatal adrenoleukodystrophy [NALD] and infantile Refsum disease [IRD]) may present in the newborn period, but generally comes to attention later because of developmental delays, hearing loss, and/or visual impairment. Liver dysfunction may lead to a vitamin K-responsive coagulopathy. Children have also come to attention with episodes of hemorrhage; several children have presented in the first year of life with intracranial bleeding.</p><p>The clinical course is variable: while many children are very hypotonic, many learn to walk and talk.</p><p>Intermediate/milder ZSD is a progressive disorder with hearing and vision worsening with time. Some individuals may develop progressive degeneration of CNS myelin, a leukodystrophy, which may lead to loss of previously acquired skills and ultimately death.</p><p>Children who survive the first year and who have a non-progressive course have a 77% probability of reaching school age [<a class="bk_pop" href="#pbd.REF.pollthe.2004.333">Poll-The et al 2004</a>]. Some have normal intellect. They are at risk for adrenal insufficiency over time. Typically, they also have ameliogenesis imperfecta of the secondary teeth.</p><p><b>Other.</b> Individuals with atypical ZSD do not show sensory losses but have ataxia and peripheral neuropathy, and may have <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts (e.g., those with <i>PEX2</i>-ZSD [<a class="bk_pop" href="#pbd.REF.sevin.2011.8">Sevin et al 2011</a>], <i>PEX11&#x003b2;-</i>ZSD [<a class="bk_pop" href="#pbd.REF.ebberink.2012.307">Ebberink et al 2012</a>], <i>PEX10</i>-ZSD [<a class="bk_pop" href="#pbd.REF.steinberg.2009.109">Steinberg et al 2009</a>], <i>PEX12</i>-ZSD [<a class="bk_pop" href="#pbd.REF.gootjes.2004.2077">Gootjes et al 2004</a>], and <i>PEX16</i>-ZSD [<a class="bk_pop" href="#pbd.REF.ebberink.2010.608">Ebberink et al 2010</a>]).</p><p>Note that although Heimler syndrome [<a class="bk_pop" href="#pbd.REF.ratbi.2015.535">Ratbi et al 2015</a>, <a class="bk_pop" href="#pbd.REF.ratbi.2016.507">Ratbi et al 2016</a>, <a class="bk_pop" href="#pbd.REF.smith.2016.1565">Smith et al 2016</a>] and ataxia (see <a class="bk_pop" href="#pbd.REF.r_gal.2010.259">R&#x000e9;gal et al [2010]</a>, <a class="bk_pop" href="#pbd.REF.renaud.2016.1552">Renaud et al [2016]</a>) have been reported as unique phenotypes associated with PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defects, the authors consider them part of the ZSD continuum. In general, individuals described as having these milder phenotypes do not have &#x02013; on screening assays &#x02013; the biochemical profile typical of ZSD (<a class="figpopup" href="/books/NBK1448/table/pbd.T.screening_assays_for_zsd/?report=objectonly" target="object" rid-figpopup="figpbdTscreeningassaysforzsd" rid-ob="figobpbdTscreeningassaysforzsd">Table 1</a>).</p><p><b>Neuroimaging.</b> MRI may identify cortical gyral abnormalities and germinolytic cysts that are highly suggestive of severe ZSD. Other brain MRI findings have been identified over time in individuals with milder ZSD.</p><p>In a small number of individuals with ZSD, diffusion-weighted imaging and diffusion tensor imaging can be used to discern white matter damage not detected by standard imaging [<a class="bk_pop" href="#pbd.REF.patay.2005.2284">Patay 2005</a>]. A demyelinating leukodystrophy can occur, but it is not clear which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are at increased risk for this development, or how it progresses in the individual.</p></div><div id="pbd.Phenotype_Correlations_by_Gene"><h3>Phenotype Correlations by Gene</h3><p>Biallelic pathogenic variants in the two most commonly involved genes, <i>PEX1</i> and <i>PEX6</i>, are associated with the full continuum of clinical phenotypes. This clinical variability, in general, is also found in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PEX10</i>, <i>PEX12</i>, and <i>PEX26</i>. Although in the past, defects in some of the less common PEX genes appeared to be associated with severe clinical phenotypes, more recently the phenotypic spectrum of defects in all PEX genes has been found to include both severely and mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Overall clinical and biochemical severity appears to be most related to the <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> and not a particular PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div><div id="pbd.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>A general relationship appears to exist among the <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>, cellular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., import of peroxisomal matrix proteins), and clinical phenotype [<a class="bk_pop" href="#pbd.REF.moser.1999.316">Moser 1999</a>]. PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defects are associated with <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants; hence, variants that abolish activity (e.g., large deletions, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift variants) are most severe. In contrast, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that retain some residual function are less severe regarding the effect on peroxisome assembly; however, it should be noted that not all missense variants have residual activity.</p><p>Due to the overall rarity of ZSD the opportunities to rigorously assess <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are limited. The <i>PEX1</i> variants <a class="figpopup" href="/books/NBK1448/table/pbd.T.pex_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figpbdTpexpathogenicvariantsdiscussed" rid-ob="figobpbdTpexpathogenicvariantsdiscussed">p.Ile700TyrfsTer42</a> and <a class="figpopup" href="/books/NBK1448/table/pbd.T.pex_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figpbdTpexpathogenicvariantsdiscussed" rid-ob="figobpbdTpexpathogenicvariantsdiscussed">p.Gly843Asp</a> are exceptions, as hundreds of individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for these variants have been identified (mostly in molecular research studies or clinical laboratories and not as part of a thorough natural history assessment).</p><ul><li class="half_rhythm"><div>Homozygosity for <i>PEX1</i>
<a class="figpopup" href="/books/NBK1448/table/pbd.T.pex_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figpbdTpexpathogenicvariantsdiscussed" rid-ob="figobpbdTpexpathogenicvariantsdiscussed">p.Ile700TyrfsTer42</a> is associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div></li><li class="half_rhythm"><div>Homozygosity for <i>PEX1</i>
<a class="figpopup" href="/books/NBK1448/table/pbd.T.pex_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figpbdTpexpathogenicvariantsdiscussed" rid-ob="figobpbdTpexpathogenicvariantsdiscussed">p.Gly843Asp</a> has to date been associated with a milder ZSD <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and sometimes with an intermediate phenotype [<a class="bk_pop" href="#pbd.REF.pollthe.2004.333">Poll-The et al 2004</a>]. More recently, an adult with a normal neurologic examination and an ocular phenotype was reported [<a class="bk_pop" href="#pbd.REF.majewski.2011.593">Majewski et al 2011</a>].</div></li></ul></div><div id="pbd.Nomenclature"><h3>Nomenclature</h3><p>Peroxisome biogenesis disorders (PBD) can be divided into two subtypes: the Zellweger spectrum disorder (ZSD) and the rhizomelic chondrodysplasia punctata spectrum, of which rhizomelic chondrodysplasia punctata type 1 (<a href="/books/n/gene/rcdp/">RCDP1</a>) is one subtype. RCDP1 is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>PEX7</i>, the receptor that recognizes peroxisome enzymes containing peroxisomal targeting signal 2. Although individuals with RCDP1 have a perturbation in matrix protein import consistent with a peroxisomal assembly defect, they have a biochemical, cellular, and clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> distinct from ZSD. (See <a href="/books/n/gene/rcdp/">Rhizomelic Chondrodysplasia Punctata Type 1</a> for an in-depth description.)</p><p>ZSD may also have been referred to in the past as cerebrohepatorenal syndrome, generalized peroxisomal disorders, Zellweger syndrome, neonatal adrenoleukodystrophy, or infantile Refsum disease (also known as infantile phytanic acid oxidase deficiency). Some individuals later shown to have ZSD were initially described as having hyperpipecolatemia. The current preferred terminology is ZSD &#x02013; of severe, intermediate, or milder phenotypes &#x02013; in order to recognize the common etiology, variations, and atypical presentations now being documented in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in any one of the 13 ZSD-PEX genes.</p><p>Of note, although Heimler syndrome [<a class="bk_pop" href="#pbd.REF.ratbi.2015.535">Ratbi et al 2015</a>, <a class="bk_pop" href="#pbd.REF.ratbi.2016.507">Ratbi et al 2016</a>, <a class="bk_pop" href="#pbd.REF.smith.2016.1565">Smith et al 2016</a>] and ataxia (see <a class="bk_pop" href="#pbd.REF.r_gal.2010.259">R&#x000e9;gal et al [2010]</a>, <a class="bk_pop" href="#pbd.REF.renaud.2016.1552">Renaud et al [2016]</a>) have been reported as unique phenotypes associated with PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defects, the authors consider them part of the ZSD continuum.</p><p>Note: <a href="/books/n/gene/refsum/">Refsum disease</a> is clinically and molecularly distinct from infantile Refsum disease (see <a href="#pbd.Differential_Diagnosis">Differential Diagnosis</a>).</p></div><div id="pbd.Prevalence"><h3>Prevalence</h3><p>In the past the incidence of ZSD had been estimated at about 1:50,000 [<a class="bk_pop" href="#pbd.REF.gould.2001">Gould et al 2001</a>]. However, recent data from the first two years eight months of New York state <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> for <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> adrenoleukodystrophy (X-ALD) (using biochemical testing that also detects ZSD) identified ZSD in eight of 630,000 newborns (incidence of 1 in 78,750) [<a class="bk_pop" href="#pbd.REF.moser.2016.15">Moser et al 2016</a>].</p><p>Since <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> for X-ALD has been added to the recommended uniform screening panel (RUSP) [<a class="bk_pop" href="#pbd.REF.kemper.2017.121">Kemper et al 2017</a>], it is expected that as more states add X-ALD to their newborn screening panels data on the incidence of ZSD in the United States will be further refined. Nonetheless, any estimate relying on a biochemical assay will be an underestimate because such assays will fail to detect very mild ZSD not associated with a definitive biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>ZSD occurs worldwide; variation is observed among populations. The main diagnostic center for peroxisomal diseases in Japan reported only 31 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals over a 20-year period, with an estimated birth prevalence of 1:500,000 [<a class="bk_pop" href="#pbd.REF.shimozawa.2003.40">Shimozawa et al 2003</a>]. This lower incidence in Japan is mainly due to the absence of the common European <i>PEX1</i> variants <a class="figpopup" href="/books/NBK1448/table/pbd.T.pex_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figpbdTpexpathogenicvariantsdiscussed" rid-ob="figobpbdTpexpathogenicvariantsdiscussed">p.Ile700TyrfsTer42</a> and <a class="figpopup" href="/books/NBK1448/table/pbd.T.pex_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figpbdTpexpathogenicvariantsdiscussed" rid-ob="figobpbdTpexpathogenicvariantsdiscussed">p.Gly843Asp</a>.</p></div></div><div id="pbd.Genetically_Related_Allelic_Disorder"><h2 id="_pbd_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> have been associated with mutation of the 13 ZSD-PEX genes (see <a class="figpopup" href="/books/NBK1448/table/pbd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figpbdTmoleculargenetictestingusedin" rid-ob="figobpbdTmoleculargenetictestingusedin">Table 2</a>).</p></div><div id="pbd.Differential_Diagnosis"><h2 id="_pbd_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of Zellweger spectrum disorder (ZSD) varies with age at presentation and most prominent feature of the presentation.</p><p>ZSD in newborns is most often confused with other conditions that result in profound hypotonia including Down syndrome, other <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormalities, <a href="/books/n/gene/pws/">Prader-Willi syndrome</a>, <a href="/books/n/gene/sma/">spinal muscular atrophy</a>, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> <a href="/books/n/gene/myotonic-d/">myotonic dystrophy type 1</a>, and congenital myopathies such as <a href="/books/n/gene/mtm/">X-linked myotubular myopathy</a> and multiminicore disease (OMIM <a href="https://omim.org/entry/606210" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606210</a>, <a href="https://omim.org/entry/180901" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">180901</a>).</p><p>Older children have been initially presumed to have <a href="/books/n/gene/usher1/">Usher syndrome type I</a> or <a href="/books/n/gene/usher2/">Usher syndrome type II</a> and other disorders of sensorineural hearing loss and retinitis pigmentosa, Leber <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> amaurosis [<a class="bk_pop" href="#pbd.REF.lambert.1989.624">Lambert et al 1989</a>, <a class="bk_pop" href="#pbd.REF.michelakakis.2004.146">Michelakakis et al 2004</a>] (see also <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>, <a href="/books/n/gene/lca-ov/">Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy Overview</a>, and <a href="/books/n/gene/rp-overview/">Retinitis Pigmentosa Overview</a>), <a href="/books/n/gene/cockayne/">Cockayne syndrome</a>, or congenital infections.</p><p>Leukodystrophies may result from lysosomal storage diseases including <a href="/books/n/gene/krabbe/">Krabbe disease</a> and <a href="/books/n/gene/mld/">metachromatic leukodystrophy</a>, from <a href="/books/n/gene/mt-overview/">mitochondrial disease</a>, or from <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a> (see <a class="bk_pop" href="#pbd.REF.tran.2014.262">Tran et al [2014]</a> for an example of a PEX6 defect mistaken for X-ALD), and often are the first consideration (see also <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>).</p><p>At least 15% of individuals with a ZSD clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and demonstrating increased plasma VLCFA concentration actually have a single-enzyme deficiency of peroxisomal &#x003b2;-oxidation (i.e., D-bifunctional enzyme deficiency or acyl-CoA oxidase deficiency) and do not have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><ul><li class="half_rhythm"><div>D-bifunctional enzyme deficiency (OMIM <a href="http://omim.org/entry/261515" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">261515</a>) is more common and in general more severe, often presenting with severe seizures within the first days of life; thus, it more closely resembles severe ZSD. The milder forms are at risk of developing a leukodystrophy.</div></li><li class="half_rhythm"><div>Acyl-CoA oxidase deficiency (OMIM <a href="http://omim.org/entry/264470" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">264470</a>) has a less pronounced biochemical and clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and in general follows a disease course more similar to intermediate ZSD (see <a class="bk_pop" href="#pbd.REF.watkins.1995.472">Watkins et al [1995]</a> for comparison of the disorders).</div></li><li class="half_rhythm"><div>Other rarer single-enzyme defects affecting &#x003b2;-oxidation include SCP2 and ACDB5 [<a class="bk_pop" href="#pbd.REF.abusafieh.2013.236">Abu-Safieh et al 2013</a>, <a class="bk_pop" href="#pbd.REF.ferdinandusse.2017.330">Ferdinandusse et al 2017</a>].</div></li></ul><p>It is important to differentiate peroxisome assembly defects from other single-enzyme defects of peroxisomal metabolism. Children may be erroneously diagnosed as having a variant of <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a> [<a class="bk_pop" href="#pbd.REF.tran.2014.262">Tran et al 2014</a>] or adult <a href="/books/n/gene/refsum/">Refsum disease</a>. This most often occurs secondary to lack of familiarity with the underlying defect and the unfortunate redundancy of eponyms.</p><ul><li class="half_rhythm"><div><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> adrenoleukodystrophy is characterized by an elevation of plasma concentrations of VLCFAs without other abnormalities of peroxisomes. Males with this condition are almost always developmentally normal before their initial presentation.</div></li><li class="half_rhythm"><div>Adult Refsum disease is caused by pathogenic variants in <i>PHYH</i> (encoding phytanoyl-CoA hydroxylase) in more than 90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and pathogenic variants in <i>PEX7</i> (encoding the PTS2 receptor) in fewer than 10% of affected individuals. Individuals with adult Refsum disease have a biochemical profile distinct from ZSD and are developmentally normal before presenting in their late teens or twenties.</div></li></ul><p>An increase in plasma VLCFA concentration consistent with a defect in peroxisomal fatty acid metabolism can also be observed in CADDS (OMIM <a href="http://omim.org/entry/300475" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300475</a>), a contiguous <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a> with a <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> spanning <i>ABCD1</i> and <i>BAP31</i> [<a class="bk_pop" href="#pbd.REF.corzo.2002.1520">Corzo et al 2002</a>].</p><p><b><i>DNM1L</i></b> (dynamin 1-like) (OMIM <a href="http://omim.org/entry/614388" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614388</a>) is characterized by encephalopathy due to defective mitochondrial and peroxisomal fission 1. In the initial report a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>DNM1L</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was detected in an infant [<a class="bk_pop" href="#pbd.REF.waterham.2007.1736">Waterham et al 2007</a>]. Clinical findings were mild <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, truncal hypotonia, absent tendon reflexes, microcephaly, optic atrophy, failure to thrive, and severe developmental delay. Biochemical findings included mildly elevated plasma VLCFA and persistent lactic acidemia. Immunocytochemical studies in cultured fibroblasts suggested a defect in mitochondrial and peroxisomal fission. Several other individuals with a <i>de novo</i>
<i>DNM1L</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant have been reported [<a class="bk_pop" href="#pbd.REF.sheffer.2016.1603">Sheffer et al 2016</a>, <a class="bk_pop" href="#pbd.REF.vanstone.2016.1084">Vanstone et al 2016</a>], as well as two individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <i>DNM1L</i> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants [<a class="bk_pop" href="#pbd.REF.yoon.2016.313">Yoon et al 2016</a>].</p></div><div id="pbd.Management"><h2 id="_pbd_Management_">Management</h2><div id="pbd.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Zellweger spectrum disorder (ZSD), the following are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div class="half_rhythm">Feeding and nutrition assessment</div></li><li class="half_rhythm"><div class="half_rhythm">Hearing assessment</div></li><li class="half_rhythm"><div class="half_rhythm">Comprehensive ophthalmologic assessment</div><div class="half_rhythm">Note: Electroretinogram (ERG) and visual field testing are useful in the diagnosis of retinal dystrophy. OCT examinations in compliant patients have shown cystoid macular edema [<a class="bk_pop" href="#pbd.REF.ventura.2016.75">Ventura et al 2016</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Liver function testing</div></li><li class="half_rhythm"><div class="half_rhythm">Neurologic examination as well as possible brain MRI and EEG if findings warrant</div></li><li class="half_rhythm"><div class="half_rhythm">Developmental assessment</div></li><li class="half_rhythm"><div class="half_rhythm">Evaluation of adrenal function given that adrenal insufficiency may occur during periods of stress</div></li><li class="half_rhythm"><div class="half_rhythm">Dental evaluation</div></li><li class="half_rhythm"><div class="half_rhythm">Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="pbd.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><a class="bk_pop" href="#pbd.REF.klouwer.2015">Klouwer et al [2015]</a> (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666198/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>) and <a class="bk_pop" href="#pbd.REF.braverman.2016">Braverman et al [2016]</a> (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214431/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>) have published management and treatment guidelines for ZSD. Treatment focuses on symptomatic therapy.</p><p><b>Feeding and nutrition.</b> Supplying adequate calorie intake for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children often entails the placement of a gastrostomy tube to allow simpler home management. No specific metabolic diet is recommended. With many children having some degree of malabsorption, elemental formulas may be better tolerated.</p><p>Note: A diet low in phytanic acid has been proposed, based mainly on the weak analogy with adult <a href="/books/n/gene/refsum/">Refsum disease</a>, in which accumulation of phytanic acid is pathogenic and treatment involves restricted dietary intake of phytanic acid (including avoidance of full-fat cow's milk products and high-fat meat products from ruminants). Its effectiveness in ZSD has never been proven. All standard infant formulas are already low in phytanic acid.</p><p><b>Hearing.</b> Hearing aids should be used in children found to have hearing impairment. (See also <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a> for discussion of management issues.)</p><p><b>Vision.</b> Cataract removal in early infancy to preserve vision is appropriate. Glasses should be used as needed to correct refractive errors.</p><p><b>Liver.</b> Supplementation of vitamin K and other fat-soluble vitamins is recommended.</p><p>Liver dysfunction may lead to varices that respond to sclerosing therapies.</p><p>Cholbam<sup>TM</sup> (cholic acid) supplementation to treat the liver disease in patients with ZSD has been recently approved. By providing the final C24 bile acid product, the bile acid pathway undergoes feedback inhibition, thus reducing the levels of elevated C27 bile acid intermediates that are thought to be toxic to the liver. Cholic acid therapy does in fact decrease C27 bile acid intermediates (which should be measured), but its clinical effect in ZSD is not yet known. Furthermore, cholic acid supplementation can worsen liver disease in patients with evidence of preexisting fibrosis and advanced liver disease [<a class="bk_pop" href="#pbd.REF.berendse.2016.859">Berendse et al 2016</a>].</p><p><b>Neurologic.</b> Early-intervention services should be provided for those with developmental delays.</p><p>Standard antiepileptic drugs (AEDs) may be used to treat seizures. No type of AED is contraindicated. Seizures may be difficult to control despite use of appropriate medication.</p><p><b>Bone.</b> Evaluation of (1) bone density by dual-energy x-ray absorptiometry (DXA) and (2) vitamin D levels should be considered. The benefits of bisphosphonate treatment have been reported in a case report [<a class="bk_pop" href="#pbd.REF.rush.2016.33">Rush et al 2016</a>].</p><p><b>Teeth.</b> Semiannual dental visits are recommended.</p><p><b>Vaccination.</b> In addition to the usual vaccination schedule for children, patients with ZSD should receive annual influenza and respiratory syncytial virus vaccines.</p></div><div id="pbd.Surveillance"><h3>Surveillance</h3><p>Hearing should be evaluated annually.</p><p>Annual ophthalmologic evaluation is indicated. (Although electroretinogram is useful in the diagnosis of a retinal dystrophy, it is not useful in follow up; visual field testing is much more helpful.)</p><p>Coagulation factors and other synthetic liver functions should be monitored. Persons with overt hepatic dysfunction require more routine monitoring.</p><p>The use of routine neuroimaging is uncertain. Individuals with peroxisomal disorders may develop a progressive leukodystrophy. No effective therapy exists, but identification of white matter changes may explain changes in cognitive and/or motor ability.</p><p>Adrenal function should be assessed beginning at age one year and regularly thereafter.</p><p>Longer-surviving <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be monitored for hyperoxaluria, which can lead to stone formation and end-stage renal disease.</p></div><div id="pbd.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>When the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is on the milder end of the ZSD spectrum, it is appropriate to clarify the genetic status of apparently asymptomatic older and younger sibs in order to identify as early as possible those who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and, thus, would benefit from annual hearing and ophthalmologic evaluation, and routine monitoring of coagulation factors, adrenal function, and liver function. Note that <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the pathogenic variants identified in the family is warranted as the results of screening assays (<a class="figpopup" href="/books/NBK1448/table/pbd.T.screening_assays_for_zsd/?report=objectonly" target="object" rid-figpopup="figpbdTscreeningassaysforzsd" rid-ob="figobpbdTscreeningassaysforzsd">Table 1</a>) in persons at the mild end of the ZSD spectrum may be highly variable.</p><p>See <a href="#pbd.Related_Genetic_Counseling_Issues"><u>Genetic Counseling</u></a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="pbd.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="pbd.Genetic_Counseling"><h2 id="_pbd_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="pbd.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Zellweger spectrum disorder (ZSD) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="pbd.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one ZSD-PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>In general, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals do not reproduce.</div></li><li class="half_rhythm"><div>Some individuals with milder phenotypes may reproduce; the offspring of such individuals are obligate heterozygotes (carriers of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a ZSD-PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>).</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a ZSD-PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Carrier (Heterozygote) Detection</b></p><p>Carrier testing for at-risk relatives requires prior identification of the ZSD-PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> pathogenic variants in the family.</p><p>Biochemical testing is not accurate for <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> as the biochemical markers in carriers are normal.</p></div><div id="pbd.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#pbd.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="pbd.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the ZSD-PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for ZSD are possible.</p><p><b>Biochemical testing.</b> Biochemical testing in cultured fibroblasts is still valuable when molecular testing has not identified <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in a ZSD-PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. In these cases, a definitive abnormality confirmed in cultured fibroblasts could then be used for prenatal testing in cultured CVS samples or amniocytes. Note that it is important to perform studies to rule out maternal cell contamination in cultured CVS samples [<a class="bk_pop" href="#pbd.REF.steinberg.2005.38">Steinberg et al 2005</a>].</p><p>Biochemical testing of cultured amniocytes may also be useful when abnormalities suggestive of ZSD are detected on prenatal ultrasound examination.</p></div></div><div id="pbd.Resources"><h2 id="_pbd_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Global Foundation for Peroxisomal Disorders</b></div><div>5147 South Harvard Avenue</div><div>Suite 181</div><div>Tulsa OK </div><div><b>Fax:</b> 918-516-0227</div><div><b>Email:</b> contactus@thegfpd.org</div><div><a href="http://www.thegfpd.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.thegfpd.org</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Zellweger-Syndrome-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Zellweger Syndrome Information Page</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22240/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Zellweger syndrome</a></div></li><li class="half_rhythm"><div><b>United Leukodystrophy Foundation (ULF)</b></div><div>224 North Second Street</div><div>Suite 2</div><div>DeKalb IL 60115</div><div><b>Phone:</b> 800-728-5483 (toll-free); 815-748-3211</div><div><b>Fax:</b> 815-748-0844</div><div><b>Email:</b> office@ulf.org</div><div><a href="http://www.ulf.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ulf.org</a></div></li></ul></div><div id="pbd.Molecular_Genetics"><h2 id="_pbd_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="pbd.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Zellweger Spectrum Disorder: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1448/table/pbd.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pbd.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5189" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX1</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5189" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">7q21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O43933" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisome biogenesis factor 1</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX1 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX1 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX1</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX1</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5828" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX2</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5828" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q21<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P28328" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisome biogenesis factor 2</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX2 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX2 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX2</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX2</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8504" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX3</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8504" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q24<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P56589" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisomal biogenesis factor 3</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX3 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX3 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX3</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX3</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5830" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX5</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5830" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12p13<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P50542" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisomal targeting signal 1 receptor</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX5 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX5 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX5</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX5</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5190" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX6</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5190" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6p21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q13608" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisome assembly factor 2</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX6 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX6 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX6</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX6[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX6</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5192" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX10</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5192" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p36<wbr style="display:inline-block"></wbr>​.32</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O60683" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisome biogenesis factor 10</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX10 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX10 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX10</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX10[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX10</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/8799" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX11B</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=8799" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O96011" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisomal membrane protein 11B</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX11B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX11B</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX11B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX11B</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5193" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX12</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5193" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q12</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O00623" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisome assembly protein 12</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX12" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX12 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX12" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX12 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX12" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX12</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX12[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX12</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5194" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX13</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5194" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2p15</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q92968" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisomal membrane protein PEX13</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX13" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX13 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX13" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX13 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX13" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX13</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX13[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX13</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5195" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX14</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5195" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p36<wbr style="display:inline-block"></wbr>​.22</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75381" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisomal membrane protein PEX14</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX14" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX14 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX14" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX14 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX14" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX14</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX14[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX14</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9409" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX16</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9409" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p11<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y5Y5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisomal membrane protein PEX16</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX16" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX16 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX16" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX16 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX16" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX16</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX16[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX16</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5824" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX19</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5824" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q23<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P40855" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisomal biogenesis factor 19</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX19 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX19 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX19</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX19[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX19</a></td></tr><tr><td headers="hd_b_pbd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55670" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEX26</i></a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">22q11<wbr style="display:inline-block"></wbr>​.21</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q7Z412" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Peroxisome assembly protein 26</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.dbpex.org/index.php?select_db=PEX26" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbPEX, PEX26 Gene Database</a><br /><a href="http://databases.lovd.nl/shared/genes/PEX26" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX26 database</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEX26" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX26</a></td><td headers="hd_b_pbd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEX26[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEX26</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="pbd.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="pbd.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Zellweger Spectrum Disorder (<a href="/omim/170993,202370,214100,266510,600279,600414,601498,601758,601789,601791,602136,602859,603164,603360,603867,608666" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1448/table/pbd.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pbd.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/170993" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">170993</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 2; PEX2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/202370" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">202370</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS DISORDER 2B; PBD2B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/214100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">214100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/266510" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">266510</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS DISORDER 3B; PBD3B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600279" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600279</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 19; PEX19</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600414" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600414</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 5; PEX5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601498" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601498</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 6; PEX6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601758" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601758</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 12; PEX12</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601789" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601789</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 13; PEX13</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601791" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601791</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 14; PEX14</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602136" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602136</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 1; PEX1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602859" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602859</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 10; PEX10</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603164" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603164</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 3; PEX3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603360" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603360</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 16; PEX16</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603867" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603867</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 11B; PEX11B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608666" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608666</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEROXISOME BIOGENESIS FACTOR 26; PEX26</td></tr></tbody></table></div></div><div id="pbd.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Pathogenic variants in the 13 PEX genes listed in <a class="figpopup" href="/books/NBK1448/table/pbd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figpbdTmoleculargenetictestingusedin" rid-ob="figobpbdTmoleculargenetictestingusedin">Tables 2</a> and <a class="figpopup" href="/books/NBK1448/table/pbd.T.molecular_structure_of_the_13_pex/?report=objectonly" target="object" rid-figpopup="figpbdTmolecularstructureofthe13pex" rid-ob="figobpbdTmolecularstructureofthe13pex">3</a> are known to cause Zellweger spectrum disorder (ZSD) in humans. These PEX genes encode proteins required for peroxisome biogenesis called "peroxins"; the nomenclature for naming the genes is "<i>PEX</i>" followed by a number. A few of the peroxins appear to be essential for peroxisome membrane formation. However, the majority of known <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have pathogenic variants in PEX genes encoding proteins essential for the import of peroxisomal matrix proteins.</p><p><b>Peroxisomes: biogenesis and assembly.</b> At least 29 peroxins are required for peroxisome membrane biogenesis, fission, and protein import to form competent organelles. Much of our understanding of the function of these peroxins stems from work performed in a variety of yeast strains. The biogenesis of membranes is not well understood, but pathogenic <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants in three human PEX genes (<i>PEX3</i>, <i>PEX16</i>, and <i>PEX19</i>) are associated with an absence of any peroxisome membrane structures [<a class="bk_pop" href="#pbd.REF.ghaedi.2000.976">Ghaedi et al 2000</a>].</p><p>The remaining proteins encoded by the known PEX genes contribute to the machinery required for matrix protein import, a complex process currently under active study. In general, peroxisomal matrix proteins are encoded by nuclear genes that are translated on free polyribosomes.</p><p><i>PEX5</i> (also known as <i>PXR1</i>) encodes a receptor that recognizes proteins containing peroxisomal targeting sequence 1 (PTS1), defined by the carboxy terminal consensus sequence serine-lysine-leucine (SKL).</p><p><i>PEX7</i> encodes the PTS2 receptor and recognizes proteins with an N-terminal motif present in fewer matrix proteins. Pathogenic variants in <i>PEX7</i> are associated with the clinically distinct disorder <a href="/books/n/gene/rcdp/">rhizomelic chondrodysplasia punctata</a>.</p><p>Two subcomplexes within peroxisome membranes are essential for the transfer of peroxisomal enzymes from the cytosol to the peroxisome matrix. The first complex (comprising PEX13 and PEX14) plays a role in the docking of the PTS1 and PTS2 receptors and their associated proteins; the second complex (comprising PEX2, PEX10, and PEX12) appears to be part of the <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> apparatus for matrix proteins. In contrast, PEX1 and PEX6 form a complex that may play a role in the recycling of the receptors encoded by <i>PEX5</i> and <i>PEX7</i>. Epistasis studies in yeast indicate that PEX1 and PEX6 act late in the import pathway, perhaps after the translocation process [<a class="bk_pop" href="#pbd.REF.collins.2000.7516">Collins et al 2000</a>]. However, the identification of <i>PEX26</i> has shown that the encoded protein directly interacts with PEX1-PEX6 complexes. Thus, all three proteins may play a critical role in the presentation of PTS1 and PTS2 proteins to the peroxisomal membrane.</p><p><b>Peroxisomes: metabolic pathways.</b> A variety of anabolic and catabolic pathways occur in the peroxisome. &#x003b2;-oxidation and plasmalogen synthesis are two fundamental pathways localized there. The peroxisomal &#x003b2;-oxidation enzymes are distinct from the mitochondrial system. Straight-chain VLCFA &#x003b2;-oxidation requires the enzymes very-long-chain acyl-CoA synthetase, acyl-CoA oxidase, D-bifunctional protein (enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase), and peroxisomal &#x003b2;-ketothiolase. All of these proteins have PTS1 signals except for peroxisomal &#x003b2;-ketothiolase, which is imported in a proform via a PTS2 signal. These proteins also play an important role in the side-chain modification of C27 bile acids. Thus, the defect in peroxisomal fatty acid &#x003b2;-oxidation accounts for the increase in VLCFA branched-chain fatty acids (e.g., pristanic acid) and C27 bile acids. A unique branched-chain acyl-CoA oxidase is used for bile acids and pristanic acid, thus explaining why these metabolites are normal in acyl-CoA oxidase deficiency. The initial steps of plasmalogen synthesis occur in the peroxisome and the final stages of synthesis are completed in the endoplasmic reticulum. Dihydroxyacetone phosphate (DHAP)-acyl transferase and alkyl-DHAP-synthase are PTS1 and PTS2 proteins, respectively.</p><p>It is not possible to determine the defective PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> based solely on the clinical, biochemical, or cellular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. However, a good correlation often exists between the defective PEX gene, the type of <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the impact on peroxisome assembly, and clinical severity.</p><p>Research-based testing can evaluate the effect of any PEX <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> by assessing the morphology of peroxisomes in cultured fibroblasts and their ability to import proteins with a PTS1 or PTS2 signal. Catalase is often used as a marker for PTS1 import, although an antibody to carboxy terminal -SKL is quite valuable for evaluating general PTS1 import. Antibodies to &#x003b2;-ketothiolase, phytanoyl CoA hydroxylase, or alkyl DHAP synthase can be used for evaluating PTS2 import. Individuals with <i>PEX3</i>, <i>PEX16</i>, or <i>PEX19</i> <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> variants are likely to lack any peroxisomal membrane remnants, detected by immunostaining peroxisomal membrane proteins such as ALDP or PMP70. In contrast, individuals with other PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defects are likely to have peroxisomes that can be visualized if a peroxisomal membrane protein antibody is used. However, these peroxisomal structures are likely to be enlarged in size and reduced in number. The type of pathogenic variant(s) in the particular PEX gene determines the impact on PTS1 and PTS2 import. A large number of cells need to be evaluated to assess the impact on import. PTS1 or PTS2 import may be completely absent in an individual with ZSD and only minimally impaired in an individual on the milder end of the clinical spectrum [<a class="bk_pop" href="#pbd.REF.shimozawa.1999a.779">Shimozawa et al 1999a</a>].</p><p>Detailed immunocytochemical analysis in fibroblasts that are deficient in a variety of PEX genes (<i>PEX6</i>, <i>PEX5</i>, <i>PEX26</i>, <i>PEX1</i>, <i>PEX2</i> [<i>PXMP3</i>], <i>PEX13</i>) has resulted in the identification of a phenomenon called "temperature sensitivity" [<a class="bk_pop" href="#pbd.REF.imamura.1998.2089">Imamura et al 1998</a>, <a class="bk_pop" href="#pbd.REF.shimozawa.1999b.1077">Shimozawa et al 1999b</a>, <a class="bk_pop" href="#pbd.REF.imamura.2000.541">Imamura et al 2000</a>, <a class="bk_pop" href="#pbd.REF.ito.2001.321">Ito et al 2001</a>, <a class="bk_pop" href="#pbd.REF.akiyama.2002.1523">Akiyama et al 2002</a>, <a class="bk_pop" href="#pbd.REF.matsumoto.2003.233">Matsumoto et al 2003</a>]. PEX-deficient fibroblasts incubated at 37&#x000b0;C may have a more severe cellular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> based on PTS1 and PTS2 import than cell lines cultured at 30&#x000b0;C. Since this phenomenon has been described in cell lines with pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, it has been hypothesized that culturing the cells at a lower temperature allows the mutated protein to attain a more relaxed conformation that enhances function. The identification of small molecules in vivo that would mimic the effect of lowering incubation temperature may have therapeutic relevance. Similarly, culturing cells at 40&#x000b0;C can be used to exacerbate the defect in cells exhibiting a milder import phenotype. This may be particularly useful for cells exhibiting <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> [<a class="bk_pop" href="#pbd.REF.gootjes.2003.107">Gootjes et al 2003</a>].</p><div id="pbd.T.molecular_structure_of_the_13_pex" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Structure of the 13 PEX Genes Associated with ZSD</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1448/table/pbd.T.molecular_structure_of_the_13_pex/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pbd.T.molecular_structure_of_the_13_pex_lrgtbl__"><table><thead><tr><th id="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exons</th><th id="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Genomic DNA (kb)</th><th id="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> (kb)</th><th id="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Protein<br />(# of amino acids)</th></tr></thead><tbody><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX1</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">41.5</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.9</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1,283</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX2</i> (<i>PXMP3</i>)</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7.4</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.5</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">626</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX3</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">39</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.1</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">373</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX5</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18.9</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.8</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">602 &#x00026; 639</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX6</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15.1</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2.4</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">980</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX10</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7.8</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">326 &#x00026; 345&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX11b</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7.5</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.7</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">259</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX12</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.8</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.1</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">359</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX13</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">31.2</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.2</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">403</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX14</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">135.5</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1.1</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">377</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX16</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8.4</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">346</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX19</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.7</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.9</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">299</td></tr><tr><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX26</i></td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10.7</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.9</td><td headers="hd_h_pbd.T.molecular_structure_of_the_13_pex_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">305</td></tr></tbody></table></div></div><p>1. According to in silico analysis, it may be up to 346 amino acids, depending on <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of the alternate <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 3 acceptor site. It is unclear which is preferred in vivo.</p><p><b>Pathogenic variants.</b> PEX <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defects associated with ZSD thus far reported are due to <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants. These variants span the full gamut of DNA nucleotide substitutions and <a class="def" href="/books/n/gene/glossary/def-item/indel/">indel</a> variation (small and large) associated with human disease. <a class="bk_pop" href="#pbd.REF.ebberink.2011.59">Ebberink et al [2011]</a> provide the most comprehensive summary of PEX gene variants identified by them (in &#x0003e;600 patients) and by others as reported in the literature.</p><p><b><i>PEX1</i>.</b> The only common variants are found in <i>PEX1</i> (p.Ile700TyrfsTer42 and p.Gly843Asp) and account for its disproportionate contribution to ZSD. The <i>PEX1</i> variants represented about 63% of all alleles in 94 individuals with ZSD [<a class="bk_pop" href="#pbd.REF.steinberg.2004.252">Steinberg et al 2004</a>]. It has been proposed that the two common alleles reside on specific haplotypes and arose as founder variants [<a class="bk_pop" href="#pbd.REF.collins.1999.45">Collins &#x00026; Gould 1999</a>], suggesting that these sites are not hot spots for recurrent pathogenic variants. Approximately 80% of individuals with a <i>PEX1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have at least one of these common alleles.</p><p><b><i>PEX6.</i></b> There are no common <i>PEX6</i> variants. However, recently the <i>PEX6</i> variant c.2578C&#x0003e;T (p.Arg860Trp) was shown to be associated with ZSD in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state, acting in an apparent dominant fashion, due to allelic expression imbalance associated with the common variant c.*442_445delTAAA in the 3' UTR that disrupts one of two polyadenylation sites. Individuals who have c.*442_445delTAAA on both chromosomes are unaffected; but individuals who have c.2578C&#x0003e;T (p.Arg860Trp) on the c.*442_445delTAAA background but lack c.*442_445delTAAA on the opposite <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> have a two- to threefold increase in abnormal PEX6 compared to controls, and have biochemical and clinical features consistent with ZSD [<a class="bk_pop" href="#pbd.REF.falkenberg.2017.965">Falkenberg et al 2017</a>].</p><p><b><i>PEX10</i>.</b> The pathogenic <i>PEX10</i> variant c.814_815delCT is a common <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in the Japanese population, where it appears to have arisen once on an ancestral haplotype [<a class="bk_pop" href="#pbd.REF.shimozawa.2003.40">Shimozawa et al 2003</a>].</p><div id="pbd.T.pex_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>PEX</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1448/table/pbd.T.pex_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__pbd.T.pex_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX1</i></td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2097dupT</td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile700TyrfsTer42</td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000466.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000466<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000457.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000457<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2528G&#x0003e;A</td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly843Asp</td></tr><tr><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX6</i></td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2578C&#x0003e;T</td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg860Trp</td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000287.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000287<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000287.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000287<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX10</i></td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.814_815delCT<br />(PEX10&#x00394;814/815)</td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu272ValfsTer66</td><td headers="hd_h_pbd.T.pex_pathogenic_variants_discussed_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/24797087" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002617<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/4505715" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002608<wbr style="display:inline-block"></wbr>​.1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="pbd.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div></div></div><div id="pbd.References"><h2 id="_pbd_References_">References</h2><div id="pbd.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.braverman.2016">Braverman NE, Raymond GV, Rizzo WB, Moser AB, Wilkinson ME, Stone EM, Steinberg SJ, Wangler MF, Rush ET, Hacia JG, Bose M. Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines. Available <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214431/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2016. Accessed 5-29-19. [<a href="/pmc/articles/PMC5214431/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5214431</span></a>] [<a href="/pubmed/26750748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26750748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.klouwer.2015">Klouwer FC, Berendse K, Ferdinandusse S, Wanders RJ, Engelen M, Poll-The BT. Zellweger spectrum disorders: clinical overview and management approach. Available <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666198/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2015. Accessed 5-29-19.</div></li></ul></div><div id="pbd.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.abusafieh.2013.236">Abu-Safieh L, Alrashed M, Anazi S, Alkuraya H, Khan AO, Al-Owain M, Al-Zahrani J, Al-Abdi L, Hashem M, Al-Tarimi S, Sebai MA, Shamia A, Ray-Zack MD, Nassan M, Al-Hassnan ZN, Rahbeeni Z, Waheeb S, Alkharashi A, Abboud E, Al-Hazzaa SA, Alkuraya FS. Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes. <span><span class="ref-journal">Genome Res. </span>2013;<span class="ref-vol">23</span>:236–47.</span> [<a href="/pmc/articles/PMC3561865/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3561865</span></a>] [<a href="/pubmed/23105016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23105016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.akiyama.2002.1523">Akiyama N, Ghaedi K, Fujiki Y. A novel pex2 mutant: catalase-deficient but temperature-sensitive PTS1 and PTS2 import. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2002;<span class="ref-vol">293</span>:1523–9.</span> [<a href="/pubmed/12054689" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12054689</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.berendse.2014.133">Berendse K, Engelen M, Linthorst GE, van Trotsenburg AS, Poll-The BT. High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:133.</span> [<a href="/pmc/articles/PMC4164755/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4164755</span></a>] [<a href="/pubmed/25179809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25179809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.berendse.2016.859">Berendse K, Klouwer FC, Koot BG, Kemper EM, Ferdinandusse S, Koelfat KV, Lenicek M, Schaap FG, Waterham HR, Vaz FM, Engelen M, Jansen PL, Wanders RJ, Poll-The BT. Cholic acid therapy in Zellweger spectrum disorders. <span><span class="ref-journal">J Inherit Metab Dis. </span>2016;<span class="ref-vol">39</span>:859–68.</span> [<a href="/pmc/articles/PMC5065608/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5065608</span></a>] [<a href="/pubmed/27469511" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27469511</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.braverman.2016.313">Braverman NE, Raymond GV, Rizzo WB, Moser AB, Wilkinson ME, Stone EM, Steinberg SJ, Wangler MF, Rush ET, Hacia JG, Bose M. Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. <span><span class="ref-journal">Mol Genet Metab. </span>2016;<span class="ref-vol">117</span>:313–21.</span> [<a href="/pmc/articles/PMC5214431/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5214431</span></a>] [<a href="/pubmed/26750748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26750748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.collins.1999.45">Collins CS, Gould SJ. Identification of a common PEX1 mutation in Zellweger syndrome. <span><span class="ref-journal">Hum Mutat. </span>1999;<span class="ref-vol">14</span>:45–53.</span> [<a href="/pubmed/10447258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10447258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.collins.2000.7516">Collins CS, Kalish JE, Morrell JC, McCaffery JM, Gould SJ. The peroxisome biogenesis factors pex4p, pex22p, pex1p, and pex6p act in the terminal steps of peroxisomal matrix protein import. <span><span class="ref-journal">Mol Cell Biol. </span>2000;<span class="ref-vol">20</span>:7516–26.</span> [<a href="/pmc/articles/PMC86304/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC86304</span></a>] [<a href="/pubmed/11003648" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11003648</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.corzo.2002.1520">Corzo D, Gibson W, Johnson K, Mitchell G, LePage G, Cox GF, Casey R, Zeiss C, Tyson H, Cutting GR, Raymond GV, Smith KD, Watkins PA, Moser AB, Moser HW, Steinberg SJ. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:1520–31.</span> [<a href="/pmc/articles/PMC419992/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC419992</span></a>] [<a href="/pubmed/11992258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11992258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ebberink.2010.608">Ebberink MS, Csanyi B, Chong WK, Denis S, Sharp P, Mooijer PA, Dekker CJ, Spooner C, Ngu LH, De Sousa C, Wanders RJ, Fietz MJ, Clayton PT, Waterham HR, Ferdinandusse S. Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:608–15.</span> [<a href="/pubmed/20647552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20647552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ebberink.2012.307">Ebberink MS, Koster J, Visser G, Spronsen F, Stolte-Dijkstra I, Smit GP, Fock JM, Kemp S, Wanders RJ, Waterham HR. A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11&#x003b2; gene. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:307–13.</span> [<a href="/pubmed/22581968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22581968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ebberink.2011.59">Ebberink MS, Mooijer PA, Gootjes J, Koster J, Wanders RJ, Waterham HR. Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. <span><span class="ref-journal">Hum Mutat. </span>2011;<span class="ref-vol">32</span>:59–69.</span> [<a href="/pubmed/21031596" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21031596</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.falkenberg.2017.965">Falkenberg KD, Braverman NE, Moser AB, Steinberg SJ, Klouwer FCC, Schl&#x000fc;ter A, Ruiz M, Pujol A, Engvall M, Naess K, van Spronsen F, K&#x000f6;rver-Keularts I, Rubio-Gozalbo ME, Ferdinandusse S, Wanders RJA, Waterham HR. Allelic expression imbalance promoting a mutant PEX6 allele causes Zellweger spectrum disorder. <span><span class="ref-journal">Am J Hum Genet. </span>2017;<span class="ref-vol">101</span>:965–76.</span> [<a href="/pmc/articles/PMC5812895/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5812895</span></a>] [<a href="/pubmed/29220678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29220678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ferdinandusse.2017.330">Ferdinandusse S, Falkenberg KD, Koster J, Mooyer PA, Jones R, van Roermund CWT, Pizzino A, Schrader M, Wanders RJA, Vanderver A, Waterham HR. ACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism. <span><span class="ref-journal">J Med Genet. </span>2017;<span class="ref-vol">54</span>:330–7.</span> [<a href="/pubmed/27799409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27799409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ghaedi.2000.976">Ghaedi K, Honsho M, Shimozawa N, Suzuki Y, Kondo N, Fujiki Y. PEX3 is the causal gene responsible for peroxisome membrane assembly-defective Zellweger syndrome of complementation group G. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">67</span>:976–81.</span> [<a href="/pmc/articles/PMC1287899/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1287899</span></a>] [<a href="/pubmed/10968777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10968777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.gootjes.2003.107">Gootjes J, Mandel H, Mooijer PA, Roels F, Waterham HR, Wanders RJ. Resolution of the molecular defect in a patient with peroxisomal mosaicism in the liver. <span><span class="ref-journal">Adv Exp Med Biol. </span>2003;<span class="ref-vol">544</span>:107–11.</span> [<a href="/pubmed/14713221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14713221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.gootjes.2004.2077">Gootjes J, Skovby F, Christensen E, Wanders RJ, Ferdinandusse S. Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorder. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:2077–81.</span> [<a href="/pubmed/15184617" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15184617</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.gould.2001">Gould SJ, Raymond GV, Valle D. The peroxisome biogenesis disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 8 ed. New York, NY: McGraw-Hill; 2001:3181-218.</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.imamura.2000.541">Imamura A, Shimozawa N, Suzuki Y, Zhang Z, Tsukamoto T, Fujiki Y, Orii T, Osumi T, Wanders RJ, Kondo N. Temperature-sensitive mutation of PEX6 in peroxisome biogenesis disorders in complementation group C (CG-C): comparative study of PEX6 and PEX1. <span><span class="ref-journal">Pediatr Res. </span>2000;<span class="ref-vol">48</span>:541–5.</span> [<a href="/pubmed/11004248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11004248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.imamura.1998.2089">Imamura A, Tamura S, Shimozawa N, Suzuki Y, Zhang Z, Tsukamoto T, Orii T, Kondo N, Osumi T, Fujiki Y. Temperature-sensitive mutation in PEX1 moderates the phenotypes of peroxisome deficiency disorders. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:2089–94.</span> [<a href="/pubmed/9817926" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9817926</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ito.2001.321">Ito R, Huang Y, Yao C, Shimozawa N, Suzuki Y, Kondo N, Imanaka T, Usuda N, Ito M. Temperature-sensitive phenotype of Chinese hamster ovary cells defective in PEX5 gene. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2001;<span class="ref-vol">288</span>:321–7.</span> [<a href="/pubmed/11606046" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11606046</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.kemper.2017.121">Kemper AR, Brosco J, Comeau AM, Green NS, Grosse SD, Jones E, Kwon JM, Lam WK, Ojodu J, Prosser LA, Tanksley S. Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. <span><span class="ref-journal">Genet Med. </span>2017;<span class="ref-vol">19</span>:121–6.</span> [<a href="/pmc/articles/PMC5182180/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5182180</span></a>] [<a href="/pubmed/27337030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27337030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.klouwer.2015.151">Klouwer FC, Berendse K, Ferdinandusse S, Wanders RJ, Engelen M, Poll-The BT. Zellweger spectrum disorders: clinical overview and management approach. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2015;<span class="ref-vol">10</span>:151.</span> [<a href="/pmc/articles/PMC4666198/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4666198</span></a>] [<a href="/pubmed/26627182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26627182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.lambert.1989.624">Lambert SR, Kriss A, Taylor D, Coffey R, Pembrey M. Follow-up and diagnostic reappraisal of 75 patients with Leber's congenital amaurosis. <span><span class="ref-journal">Am J Ophthalmol. </span>1989;<span class="ref-vol">107</span>:624–31.</span> [<a href="/pubmed/2658617" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2658617</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.lyons.2004.191">Lyons CJ, Castano G, McCormick AQ, Applegarth D. Leopard spot retinal pigmentation in infancy indicating a peroxisomal disorder. <span><span class="ref-journal">Br J Ophthalmol. </span>2004;<span class="ref-vol">88</span>:191–2.</span> [<a href="/pmc/articles/PMC1772012/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1772012</span></a>] [<a href="/pubmed/14736770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14736770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.majewski.2011.593">Majewski J, Wang Z, Lopez I, Al Humaid S, Ren H, Racine J, Bazinet A, Mitchel G, Braverman N, Koenekoop RK. A new ocular phenotype associated with an unexpected but known systemic disorder and mutation: novel use of genomic diagnostics and exome sequencing. <span><span class="ref-journal">J Med Genet. </span>2011;2011;<span class="ref-vol">48</span>:593–6.</span> [<a href="/pubmed/21862673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21862673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.matsumoto.2003.233">Matsumoto N, Tamura S, Furuki S, Miyata N, Moser A, Shimozawa N, Moser HW, Suzuki Y, Kondo N, Fujiki Y. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">73</span>:233–46.</span> [<a href="/pmc/articles/PMC1180364/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180364</span></a>] [<a href="/pubmed/12851857" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12851857</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.michelakakis.2004.146">Michelakakis HM, Zafeiriou DI, Moraitou MS, Gootjes J, Wanders RJ. PEX1 deficiency presenting as Leber congenital amaurosis. <span><span class="ref-journal">Pediatr Neurol. </span>2004;<span class="ref-vol">31</span>:146–9.</span> [<a href="/pubmed/15301838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15301838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.moser.2016.15">Moser AB, Jones RO, Hubbard WC, Tortorelli S, Orsini JJ, Caggana M, Vogel B, Raymond GV. Newborn screening for X-linked adrenoleukodystrophy. <span><span class="ref-journal">Int J Neonatal Screen. </span>2016;<span class="ref-vol">2</span>:15.</span> [<a href="/pmc/articles/PMC6715319/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6715319</span></a>] [<a href="/pubmed/31467997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31467997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.moser.1995.13">Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuinness M, Hajra AK, Chen G, Raymond G, Liu A, Gordon D, et al.  Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. <span><span class="ref-journal">J Pediatr. </span>1995;<span class="ref-vol">127</span>:13–22.</span> [<a href="/pubmed/7541833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7541833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.moser.1999.316">Moser HW. Genotype-phenotype correlations in disorders of peroxisome biogenesis. <span><span class="ref-journal">Mol Genet Metab. </span>1999;<span class="ref-vol">68</span>:316–27.</span> [<a href="/pubmed/10527683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10527683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.patay.2005.2284">Patay Z. Diffusion-weighted MR imaging in leukodystrophies. <span><span class="ref-journal">Eur Radiol. </span>2005;<span class="ref-vol">15</span>:2284–303.</span> [<a href="/pubmed/16021451" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16021451</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.plecko.2000.121">Plecko B, Stockler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C. Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">48</span>:121–5.</span> [<a href="/pubmed/10894227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10894227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.pollthe.2004.333">Poll-The BT, Gootjes J, Duran M, De Klerk JB, Wenniger-Prick LJ, Admiraal RJ, Waterham HR, Wanders RJ, Barth PG. Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">126A</span>:333–8.</span> [<a href="/pubmed/15098231" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15098231</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.raasrothschild.2002.1062">Raas-Rothschild A, Wanders RJ, Mooijer PA, Gootjes J, Waterham HR, Gutman A, Suzuki Y, Shimozawa N, Kondo N, Eshel G, Espeel M, Roels F, Korman SH. A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:1062–8.</span> [<a href="/pmc/articles/PMC379104/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC379104</span></a>] [<a href="/pubmed/11873320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11873320</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ratbi.2015.535">Ratbi I, Falkenberg KD, Sommen M, Al-Sheqaih N, Guaoua S, Vandeweyer G, Urquhart JE, Chandler KE, Williams SG, Roberts NA, El Alloussi M, Black GC, Ferdinandusse S, Ramdi H, Heimler A, Fryer A, Lynch SA, Cooper N, Ong KR, Smith CE, Inglehearn CF, Mighell AJ, Elcock C, Poulter JA, Tischkowitz M, Davies SJ, Sefiani A, Mironov AA, Newman WG, Waterham HR, Van Camp G. Heimler syndrome is caused by hypomorphic mutations in the peroxisome-biogenesis genes PEX1 and PEX6. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">97</span>:535–45.</span> [<a href="/pmc/articles/PMC4596894/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4596894</span></a>] [<a href="/pubmed/26387595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26387595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ratbi.2016.507">Ratbi I, Jaouad IC, Elorch H, Al-Sheqaih N, Elalloussi M, Lyahyai J, Berraho A, Newman WG, Sefiani A. Severe early onset retinitis pigmentosa in a Moroccan patient with Heimler syndrome due to novel homozygous mutation of PEX1 gene. <span><span class="ref-journal">Eur J Med Genet. </span>2016;<span class="ref-vol">59</span>:507–11.</span> [<a href="/pubmed/27633571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27633571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.r_gal.2010.259">R&#x000e9;gal L, Ebberink MS, Goemans N, Wanders RJ, De Meirleir L, Jaeken J, Schrooten M, Van Coster R, Waterham HR. Mutations in PEX10 are a cause of autosomal recessive ataxia. <span><span class="ref-journal">Ann Neurol. </span>2010;<span class="ref-vol">68</span>:259–63.</span> [<a href="/pubmed/20695019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20695019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.renaud.2016.1552">Renaud M, Guissart C, Mallaret M, Ferdinandusse S, Cheillan D, Drouot N, Muller J, Claustres M, Tranchant C, Anheim M, Koenig M. Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: slowly progressive recessive ataxia. <span><span class="ref-journal">J Neurol. </span>2016;<span class="ref-vol">263</span>:1552–8.</span> [<a href="/pubmed/27230853" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27230853</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.rush.2016.33">Rush ET, Goodwin JL, Braverman NE, Rizzo WB. Low bone mineral density is a common feature of Zellweger spectrum disorders. <span><span class="ref-journal">Mol Genet Metab. </span>2016;<span class="ref-vol">117</span>:33–7.</span> [<a href="/pubmed/26643206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26643206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.sevin.2011.8">Sevin C, Ferdinandusse S, Waterham HR, Wanders RJ, Aubourg P. Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2011;<span class="ref-vol">6</span>:8.</span> [<a href="/pmc/articles/PMC3064617/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3064617</span></a>] [<a href="/pubmed/21392394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21392394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.sheffer.2016.1603">Sheffer R, Douiev L, Edvardson S, Shaag A, Tamimi K, Soiferman D, Meiner V, Saada A. Postnatal microcephaly and pain insensitivity due to a de novo heterozygous DNM1L mutation causing impaired mitochondrial fission and function. <span><span class="ref-journal">Am J Med Genet A. </span>2016;<span class="ref-vol">170</span>:1603–7.</span> [<a href="/pubmed/26992161" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26992161</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.shimozawa.1999a.779">Shimozawa N, Imamura A, Zhang Z, Suzuki Y, Orii T, Tsukamoto T, Osumi T, Fujiki Y, Wanders RJ, Besley G, Kondo N. Defective PEX gene products correlate with the protein import, biochemical abnormalities, and phenotypic heterogeneity in peroxisome biogenesis disorders. <span><span class="ref-journal">J Med Genet. </span>1999a;<span class="ref-vol">36</span>:779–81.</span> [<a href="/pmc/articles/PMC1734244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734244</span></a>] [<a href="/pubmed/10528859" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10528859</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.shimozawa.2003.40">Shimozawa N, Nagase T, Takemoto Y, Ohura T, Suzuki Y, Kondo N. Genetic heterogeneity of peroxisome biogenesis disorders among Japanese patients: Evidence for a founder haplotype for the most common PEX10 gene mutation. <span><span class="ref-journal">Am J Med Genet. </span>2003;<span class="ref-vol">120A</span>:40–3.</span> [<a href="/pubmed/12794690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12794690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.shimozawa.1999b.1077">Shimozawa N, Suzuki Y, Zhang Z, Imamura A, Toyama R, Mukai S, Fujiki Y, Tsukamoto T, Osumi T, Orii T, Wanders RJ, Kondo N. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. <span><span class="ref-journal">Hum Mol Genet. </span>1999b;<span class="ref-vol">8</span>:1077–83.</span> [<a href="/pubmed/10332040" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10332040</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.smith.2016.1565">Smith CE, Poulter JA, Levin AV, Capasso JE, Price S, Ben-Yosef T, Sharony R, Newman WG, Shore RC, Brookes SJ, Mighell AJ, Inglehearn CF. Spectrum of PEX1 and PEX6 variants in Heimler syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:1565–71.</span> [<a href="/pmc/articles/PMC5026821/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5026821</span></a>] [<a href="/pubmed/27302843" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27302843</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.steinberg.2004.252">Steinberg S, Chen L, Wei L, Moser A, Moser H, Cutting G, Braverman N. The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. <span><span class="ref-journal">Mol Genet Metab. </span>2004;<span class="ref-vol">83</span>:252–63.</span> [<a href="/pubmed/15542397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15542397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.steinberg.2005.38">Steinberg S, Katsanis S, Moser A, Cutting G. Biochemical analysis of cultured chorionic villi for the prenatal diagnosis of peroxisomal disorders: biochemical thresholds and molecular sensitivity for maternal cell contamination detection. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:38–44.</span> [<a href="/pmc/articles/PMC1735906/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735906</span></a>] [<a href="/pubmed/15635073" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15635073</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.steinberg.2009.109">Steinberg SJ, Snowden A, Braverman NE, Chen L, Watkins PA, Clayton PT, Setchell KD, Heubi JE, Raymond GV, Moser AB, Moser HW. A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009;<span class="ref-vol">32</span>:109–19.</span> [<a href="/pubmed/19127411" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19127411</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.tran.2014.262">Tran C, Hewson S, Steinberg SJ, Mercimek-Mahmutoglu S. Late-onset Zellweger spectrum disorder caused by PEX6 mutations mimicking X-linked adrenoleukodystrophy. <span><span class="ref-journal">Pediatr Neurol. </span>2014;<span class="ref-vol">51</span>:262–5.</span> [<a href="/pubmed/25079577" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25079577</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.vanstone.2016.1084">Vanstone JR, Smith AM, McBride S, Naas T, Holcik M, Antoun G, Harper ME, Michaud J, Sell E, Chakraborty P, Tetreault M, Majewski J, Baird S, Boycott KM, Dyment DA, MacKenzie A, Lines MA, et al.  DNM1L-related mitochondrial fission defect presenting as refractory epilepsy. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:1084–8.</span> [<a href="/pmc/articles/PMC5070894/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5070894</span></a>] [<a href="/pubmed/26604000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26604000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.ventura.2016.75">Ventura MJ, Wheaton D, Xu M, Birch D, Bowne SJ, Sullivan LS, Daiger SP, Whitney AE, Jones RO, Moser AB, Chen R, Wangler MF. Diagnosis of a mild peroxisomal phenotype with next-generation sequencing. <span><span class="ref-journal">Mol Genet Metab Rep. </span>2016;<span class="ref-vol">9</span>:75–78.</span> [<a href="/pmc/articles/PMC5109284/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5109284</span></a>] [<a href="/pubmed/27872819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27872819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.waterham.2007.1736">Waterham HR, Koster J, van Roermund CWT, Mooyer PAW, Wanders RJA, Loenard JV. A lethal defect of mitochondrial and peroxisomal fission. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">356</span>:1736–41.</span> [<a href="/pubmed/17460227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17460227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.watkins.1995.472">Watkins PA, McGuinness MC, Raymond GV, Hicks BA, Sisk JM, Moser AB, Moser HW. Distinction between peroxisomal bifunctional enzyme and acyl-CoA oxidase deficiencies. <span><span class="ref-journal">Ann Neurol. </span>1995;<span class="ref-vol">38</span>:472–7.</span> [<a href="/pubmed/7668838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7668838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="pbd.REF.yoon.2016.313">Yoon G, Malam Z, Paton T, Marshall CR, Hyatt E, Ivakine Z, Scherer SW, Lee KS, Hawkins C, Cohn RD., Finding of Rare Disease Genes (FORGE) in Canada Consortium Steering Committee.  Lethal disorder of mitochondrial fission caused by mutations in DNM1L. <span><span class="ref-journal">J Pediatr. </span>2016;<span class="ref-vol">171</span>:313–6.e1.</span> [<a href="/pubmed/26825290" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26825290</span></a>]</div></li></ul></div></div><div id="pbd.Chapter_Notes"><h2 id="_pbd_Chapter_Notes_">Chapter Notes</h2><p><b>Author History</b></p><p>Nancy E Braverman, MS, MD (2003 &#x02013; present)<br />Ann B Moser, BA (2003 &#x02013; present)<br />Hugo W Moser, MD (2003 &#x02013; 2007*)<br />Gerald V Raymond, MD (2003 &#x02013; present)<br />Steven J Steinberg, PhD (2003 &#x02013; present)</p><p>*Hugo W Moser, MD was Professor of Neurology and Pediatrics at Johns Hopkins University School of Medicine and former Director of the Kennedy Krieger Institute in Baltimore. He was a world-renowned expert in the field of neurogenetics. He was best known for his leadership role in understanding, diagnosing, and treating adrenoleukodystrophy (ALD). Dr Moser died of cancer on January 20, 2007 at age 82. He is greatly missed by his family, friends, colleagues, and patients.</p><p><b>Revision History</b></p><ul><li class="half_rhythm"><div>21 December 2017 (sjs) Revision: <i>PEX6</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> added</div></li><li class="half_rhythm"><div>16 November 2017 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 May 2012 (cd) Revision: to clarify that prenatal testing using biochemical methods is possible</div></li><li class="half_rhythm"><div>18 January 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 April 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 October 2004 (sjs) Revision</div></li><li class="half_rhythm"><div>12 December 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>1 August 2003 (sjs) Original submission</div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1448</span><span class="label">PMID: <a href="/pubmed/20301621" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301621</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/zap70-scid/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/archived_chapters/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1448&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1448/?report=reader">PubReader</a></li><li><a href="/books/NBK1448/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1448" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1448" style="display:none" title="Cite this Page"><div class="bk_tt">Steinberg SJ, Raymond GV, Braverman NE, et al. Zellweger Spectrum Disorder. 2003 Dec 12 [Updated 2017 Dec 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1448/pdf/Bookshelf_NBK1448.pdf">PDF version of this page</a> (286K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#pbd.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#pbd.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#pbd.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#pbd.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#pbd.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#pbd.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#pbd.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#pbd.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#pbd.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#pbd.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#pbd.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#pbd.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5830[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PEX5</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5193[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PEX12</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5190[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PEX6</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9409[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PEX16</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5189[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PEX1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1463702" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1463702" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1463702" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1463702" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24501781" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vanderver A, Tonduti D, Schiffmann R, Schmidt J, van der Knaap MS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11405337" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical, biochemical and genetic aspects and neuronal migration in peroxisome biogenesis disorders.</a><span class="source">[J Inherit Metab Dis. 2001]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical, biochemical and genetic aspects and neuronal migration in peroxisome biogenesis disorders.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Suzuki Y, Shimozawa N, Imamura A, Fukuda S, Zhang Z, Orii T, Kondo N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Inherit Metab Dis. 2001 Apr; 24(2):151-65. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301447" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rhizomelic Chondrodysplasia Punctata Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Rhizomelic Chondrodysplasia Punctata Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Braverman NE, Moser AB, Steinberg SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17041890" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients.</a><span class="source">[Hum Mutat. 2006]</span><div class="brieflinkpop offscreen_noflow">Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Krause C, Rosewich H, Thanos M, Gärtner J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mutat. 2006 Nov; 27(11):1157. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24503136" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.</a><span class="source">[Mol Genet Metab. 2014]</span><div class="brieflinkpop offscreen_noflow">The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hiebler S, Masuda T, Hacia JG, Moser AB, Faust PL, Liu A, Chowdhury N, Huang N, Lauer A, Bennett J, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2014 Apr; 111(4):522-532. Epub 2014 Jan 23.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301621" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301621" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042b0439a66ee2bac2a5aa">Zellweger Spectrum Disorder - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Zellweger Spectrum Disorder - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:37:40-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CE65EE042A49100000000004E001D&amp;ncbi_session=CE8CE65EE042B031_0078SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1448%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1448&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1448/&amp;ncbi_pagename=Zellweger Spectrum Disorder - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CE65EE042B031_0078SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>